Repositioning Candidate Details

Candidate ID: R1332
Source ID: DB11095
Source Type: approved
Compound Type: biotech
Compound Name: Desirudin
Synonyms: 63-Desulfohirudin; 63-Desulfohirudin (Hirudo Medicinalis Isoform HV1); 63-Desulfohirudin (recombinant); Desirudin; Desirudin recombinant; Hirudin desirudin
Molecular Formula: --
SMILES: --
DrugBank Description: Desirudin is a direct inhibitor of human thrombin. It has a protein structure that is similar to that of hirudin, the naturally occurring anticoagulant present in the peripharyngeal glands in the medicinal leech, Hirudo medicinalis. Hirudin is a single polypeptide chain of 65 amino acids residues and contains three disulfide bridges. Desirudin has a chemical formula of C287H440N80O110S6 with a molecular weight of 6963.52. It is mainly indicated for the prevention of deep vein thrombosis in hip replacement surgery patients. Common side effects include: Bleeding gums, collection of blood under the skin, coughing up blood, deep, dark purple bruise and difficulty with breathing or swallowing.
CAS Number: 120993-53-5
Molecular Weight:
DrugBank Indication: Indicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery.
DrugBank Pharmacology: Desirudin results in dose-dependent prolongation of the activated partial thromboplastin time (aPTT).
DrugBank MoA: Desirudin is a direct, highly selective thrombin inhibitor. Reversibly binds to the active thrombin site of free and clot-associated thrombin. Inhibits fibrin formation, activation of coagulation factors V, VII, and XIII, and thrombin-induced platelet aggregation resulting in a dose-dependent prolongation of the activated partial thromboplastin time (aPTT).
Targets: --
Inclusion Criteria: Therapeutic strategy associated